You are viewing the site in preview mode

Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study

Fig. 2

Change in cardiac fat accumulation compared to baseline values. a Pericardial fat accumulation, b epicardial fat accumulation, c paracardial fat accumulation, and d myocardial triglyceride content between empagliflozin and sitagliptin groups. Comparisons were performed by two-sample t-tests. n.s., not significant

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840